Pharma Journalist -

Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan, announced the sale of its portfolio company Corvidia Therapeutics to Novo…
Read More...

Eli Lilly and Company announced its partner Junshi Biosciences has dosed the first healthy volunteer in a study of a potential neutralizing antibody treatment designed to fight…
Read More...

The European Investment Bank (EIB) and BioNTech SE concluded a €100 million debt financing agreement to support the development of BNT162, the company’s COVID-19 vaccine programme. The…
Read More...

Clovis Oncology, Inc. announced the completion of target patient enrollment in the Clovis-sponsored Phase 3 ATHENA trial evaluating the combination of Clovis’ Rubraca (rucaparib), a…
Read More...

Grifols announced the start of production of its anti-SARS-CoV-2 hyperimmune immunoglobulin with specific antibodies using the plasma of people who have overcome the disease. It is the…
Read More...

Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest a portfolio of select non-core over-the-counter (OTC) and prescription pharmaceutical…
Read More...

Leap Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted the Company orphan drug designation for DKN-01 for the treatment of gastric and…
Read More...

RELIEF THERAPEUTICS Holding AG and its U.S. partner, NeuroRx, Inc. announced that Houston Methodist Hospital is participating in their Phase 2 clinical trial evaluating RLF-100 as a…
Read More...

Illumina, Inc. is paving the way for large-scale, next-generation sequencing-based (NGS) COVID-19 testing. Today, the U.S. Food and Drug Administration (FDA) issued an Emergency Use…
Read More...

DelMar Pharmaceuticals, Inc. and Adgero Biopharmaceuticals Holdings, Inc. announced the companies have entered into a definitive merger agreement pursuant to which DelMar, a…
Read More...